Effects of tobacco exposure on lung health and pulmonary biomarkers in young, healthy smokers aged 12–25 years: A systematic review

Expert Review of Respiratory Medicine

Volumn 1, Issue 3, 2007, Pages 403-418

  Kotz, Daniel ^a   Van de Kant, Kim ^a   Jöbsis, Quirijn ^a   Van Schayck, Constant P ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

adolescents; cigarette smoking; early detection; exhaled breath; exhaled breath condensate; lung disease; lung function; spirometry

Indexed keywords

EID: 84995438520     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.1.3.403     Document Type: Article

References (77)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease. Executive summary: NHLBI/WHO (2006).
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349, 1498–1504 (1997).
3. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 367, 1216–1219 (2006).
4. Pride NB. Assessment of long-term changes in airway function. Agents Actions Suppl. 30, 21–34 (1990).
5. Voelkel NF, MacNee W. Chronic Obstructive Lung Diseases. BC Decker Inc., London, UK (2002).
6. Horvath I, Hunt J, Barnes PJ et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 26, 523–548 (2005).
7. Effros RM, Dunning MB 3rd, Biller J et al. The promise and perils of exhaled breath condensates. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L1073 –L1080 (2004).
8. Schulze A, Mons U. Trends in cigarette smoking initiation and cessation among birth cohorts of 1926–1970 in Germany. Eur. J. Cancer Prev. 14, 477–483 (2005).
9. West R, Gilsenan A, Coste F et al. The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods. Addiction 101, 1352–1361 (2006).
10. WHO. Health behaviour in school-aged children: a WHO cross-national study. International report. WHO, Geneva, Switzerland (2000).
11. Centraal Bureau voor de Statistiek (CBS). Gerapporteerde gezondheid en leefstijl. [Reported health and life style]. (2007).
12. Taioli E, Wynder EL. Effect of the age at which smoking begins on frequency of smoking in adulthood. N. Engl. J. Med. 325, 968–969 (1991).
13. Escobedo LG, Marcus SE, Holtzman D et al. Sports participation, age at smoking initiation, and the risk of smoking among US high school students. JAMA 269, 1391–1395 (1993).
14. DiFranza JR, Rigotti NA, McNeill AD et al. Initial symptoms of nicotine dependence in adolescents. Tob. Control 9, 313–319 (2000).
15. O’Loughlin J, DiFranza J, Tyndale RF et al. Nicotine-dependence symptoms are associated with smoking frequency in adolescents. Am. J. Prev. Med. 25, 219–225 (2003).
16. Rijcken B, Britton J. Epidemiology of chronic obstructive pulmonary disease. In: Management of Chronic Obstructive Pulmonary Disease. Postma DS, Siafakas NM (Eds). European Respiratory Society Journals Ltd, Sheffield, UK 41–74 (1998).
17. Thurlbeck WM. Postnatal human lung growth. Thorax 37, 564–571 (1982).
18. Tager IB, Segal MR, Speizer FE et al. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am. Rev. Respir. Dis. 138, 837–849 (1988).
19. Merkus PJ, ten Have-Opbroek AA, Quanjer PH. Human lung growth: a review. Pediatr. Pulmonol. 21, 383–397 (1996).
20. Smith-Sivertsen T, Rortveit G. Should general practitioners screen smokers for COPD? Scand. J. Prim. Health Care 22, 196–201 (2004).
21. Enright PL, Kaminsky DA. Strategies for screening for chronic obstructive pulmonary disease. Respir. Care 48, 1194–1201 (2003).
22. van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur. Respir. J. 21, S16 –S22 (2003).
23. Barnes PJ, Chowdhury B, Kharitonov SA et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174, 6–14 (2006).
24. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 130, 1541–1546 (2006).
25. Effros RM, Su J, Casaburi R et al. Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr. Opin. Pulm. Med. 11, 135–139 (2005).
26. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin. Chim. Acta 356, 22–34 (2005).
27. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int. J. Epidemiol. 36 (3), 666–676 (2007).
28. Kunz F, Pechlaner C, Hörtnagl H et al. The smoker’s paradox and the real risk of smoking. Eur. J. Epidemiol. 20, 161–167 (2005).
29. Milaat WA, el-Ganai FM. Effects of cigarette smoking on lung function of Saudi students. Asia Pac. J. Public Health 10, 39–42 (1998).
30. Holmen TL, Barrett-Connor E, Clausen J et al. Gender differences in the impact of adolescent smoking on lung function and respiratory symptoms. The Nord-Trondelag Health Study, Norway, 1995–1997. Respir. Med. 96, 796–804 (2002).
31. Kujala P. Smoking, respiratory symptoms and ventilatory capacity in young men. Eur. J. Respir. Dis. Suppl. 114, 1–55 (1981).
32. Peters JM, Ferris BG Jr. Smoking, pulmonary function, and respiratory symptoms in a college-age group. Am. Rev. Respir. Dis. 95, 774–782 (1967).
33. Seely JE, Zuskin E, Bouhuys A. Cigarette smoking: objective evidence for lung damage in teen-agers. Science 172, 741–743 (1971).
34. Doyle LW, Olinsky A, Faber B et al. Adverse effects of smoking on respiratory function in young adults born weighing less than 1000 grams. Pediatrics 112, 565–569 (2003).
35. Prokhorov AV, Emmons KM, Pallonen UE et al. Respiratory response to cigarette smoking among adolescent smokers: a pilot study. Prev. Med. 25, 633–640 (1996).
36. Rizzi M, Sergi M, Andreoli A et al. Environmental tobacco smoke may induce early lung damage in healthy male adolescents. Chest 125, 1387–1393 (2004).
37. Tashkin DP, Clark VA, Coulson AH et al. Comparison of lung function in young nonsmokers and smokers before and after initiation of the smoking habit. A prospective study. Am. Rev. Respir. Dis. 128, 12–16 (1983).
38. Gold DR, Wang X, Wypij D et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N. Engl. J. Med. 335, 931–937 (1996).
39. Twisk JW, Staal BJ, Brinkman MN et al. Tracking of lung function parameters and the longitudinal relationship with lifestyle. Eur. Respir. J. 12, 627–634 (1998).
40. Becklake MR, Lalloo U. The ‘healthy smoker’: a phenomenon of health selection? Respiration 57, 137–144 (1990).
41. Beck GJ, Doyle CA, Schachter EN. Smoking and lung function. Am. Rev. Respir. Dis. 123, 149–155 (1981).
42. Neukirch F, Liard R, Cooreman J et al. Prevalence of respiratory symptoms in Parisian teenagers according to smoking habits. J. Epidemiol. Community Health 36, 202–204 (1982).
43. Lebowitz MD, Holberg CJ, Knudson RJ et al. Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function. Am. Rev. Respir. Dis. 136, 69–75 (1987).
44. Tager IB, Munoz A, Rosner B et al. Effect of cigarette smoking on the pulmonary function of children and adolescents. Am. Rev. Respir. Dis. 131, 752–759 (1985).
45. Lebowitz MD, Holberg CJ. Effects of parental smoking and other risk factors on the development of pulmonary function in children and adolescents. Analysis of two longitudinal population studies. Am. J. Epidemiol. 128, 589–597 (1988).
46. Tager IB, Segal MR, Munoz A et al. The effect of maternal cigarette smoking on the pulmonary function of children and adolescents. Analyses of data from two populations. Am. Rev. Respir. Dis. 136, 1366–1370 (1987).
47. Holmen TL, Barrett-Connor E, Clausen J et al. Physical exercise, sports, and lung function in smoking versus nonsmoking adolescents. Eur. Respir. J. 19, 8–15 (2002).
48. 1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am. J. Respir. Crit. Care Med. 165, 1480–1488 (2002).
49. Walter S, Richard J. Longitudinal study of lung function development in a cohort of Indian medical students: interaction of respiratory allergy and smoking. Indian J. Physiol. Pharmacol. 35, 44–48 (1991).
50. van Helden SN, Hoal-van Helden EG, van Helden PD. Factors influencing peak expiratory flow in teenage boys. S. Afr. Med. J. 91, 996–1000 (2001).
51. Louie D. The effects of cigarette smoking on cardiopulmonary function and exercise tolerance in teenagers. Can. Respir. J. 8, 289–291 (2001).
52. Backhouse CI. Peak expiratory flow in youths with varying cigarette smoking habits. Br. Med. J. 1, 360–362 (1975).
53. Twisk JW, Kemper HC, Mellenbergh DJ et al. Factors influencing tracking of cholesterol and high-density lipoprotein: the Amsterdam Growth and Health Study. Prev. Med. 25, 355–364 (1996).
54. Twisk JW, Kemper HC, Mellenbergh GJ. Mathematical and analytical aspects of tracking. Epidemiol. Rev. 16, 165–183 (1994).
55. Garey KW, Neuhauser MM, Robbins RA et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 125, 22–26 (2004).
56. Corrigall WA, Zack M, Eissenberg T et al. Acute subjective and physiological responses to smoking in adolescents. Addiction 96, 1409–1417 (2001).
57. Gessner C, Scheibe R, Wotzel M et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir. Med. 99, 1229–1240 (2005).
58. Gianazza E, Allegra L, Bucchioni E et al. Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am. J. Med. 117, 51–54 (2004).
59. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur. Respir. J. 21, 589–593 (2003).
60. Corradi M, Pesci A, Casana R et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 8, 26–30 (2003).
61. Hogman M, Holmkvist T, Walinder R et al. Increased nitric oxide elimination from the airways after smoking cessation. Clin. Sci. 103, 15–19 (2002).
62. Malinovschi A, Janson C, Holmkvist T et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur. Respir. J. 28, 339–345 (2006).
63. Robbins RA, Millatmal T, Lassi K et al. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest 112, 313–318 (1997).
64. Nowak D, Antczak A, Krol M et al. Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur. Respir. J. 9, 652–657 (1996).
65. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic. Biol. Med. 30, 178–186 (2001).
66. Montuschi P, Collins JV, Ciabattoni G et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med. 162, 1175–1177 (2000).
67. Dekhuijzen PN, Aben KK, Dekker I et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154, 813–816 (1996).
68. Corradi M, Montuschi P, Donnelly LE et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 163, 854–858 (2001).
69. Bucchioni E, Kharitonov SA, Allegra L et al. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir. Med. 97, 1299–1302 (2003).
70. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 58, 294–298 (2003).
71. Lawrence D, Fagan P, Backinger CL et al. Cigarette smoking patterns among young adults aged 18–24 years in the United States. Nicotine Tob. Res. 9, 687–697 (2007).
72. Effros RM, Biller J, Foss B et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am. J. Respir. Crit. Care Med. 168, 1500–1505 (2003).
73. Effros RM, Casaburi R, Su J et al. The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am. J. Respir. Crit. Care Med. 173, 386–392 (2006).
74. Bize RBB, Mueller Y, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst. Rev. 4, CD004705 (2005).
75. Wilt TJ, Niewoehner D, Kane RL et al. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob. Res. 9, 21–32 (2007).
76. Wilt TJ, Niewoehner D, Kim C-B et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence Report/Technology Assessment No. 121 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290–02–0009.) AHRQ Publication No. 05-E017–2. MD, USA: Agency for Healthcare Research and Quality. September (2005).
77. Grimshaw GM, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst. Rev. 4, CD003289 (2006).